A detailed history of Los Angeles Capital Management LLC transactions in Insmed Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 10,179 shares of INSM stock, worth $751,719. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,179
Previous 3,844 164.8%
Holding current value
$751,719
Previous $257,000 189.11%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$62.0 - $79.01 $392,770 - $500,528
6,335 Added 164.8%
10,179 $743,000
Q2 2024

Aug 05, 2024

BUY
$22.0 - $69.71 $84,568 - $267,965
3,844 New
3,844 $257,000
Q2 2021

Aug 05, 2021

SELL
$24.17 - $36.01 $489,587 - $729,418
-20,256 Closed
0 $0
Q1 2021

May 05, 2021

SELL
$32.28 - $44.3 $442,591 - $607,397
-13,711 Reduced 40.37%
20,256 $689,000
Q4 2020

Feb 04, 2021

SELL
$31.45 - $40.54 $10,913 - $14,067
-347 Reduced 1.01%
33,967 $1.13 Million
Q3 2020

Nov 02, 2020

BUY
$26.0 - $34.5 $47,580 - $63,135
1,830 Added 5.63%
34,314 $1.1 Million
Q2 2020

Aug 05, 2020

SELL
$14.11 - $29.42 $120,358 - $250,952
-8,530 Reduced 20.8%
32,484 $894,000
Q1 2020

May 04, 2020

BUY
$13.63 - $33.98 $215,776 - $537,937
15,831 Added 62.86%
41,014 $657,000
Q4 2019

Feb 07, 2020

BUY
$16.12 - $24.98 $58,757 - $91,052
3,645 Added 16.92%
25,183 $601,000
Q3 2019

Nov 07, 2019

BUY
$15.49 - $25.78 $16,109 - $26,811
1,040 Added 5.07%
21,538 $380,000
Q1 2019

Apr 25, 2019

BUY
$13.91 - $31.15 $51,327 - $114,943
3,690 Added 21.95%
20,498 $596,000
Q4 2018

Feb 11, 2019

SELL
$11.6 - $18.7 $545,954 - $880,115
-47,065 Reduced 73.69%
16,808 $221,000
Q3 2018

Nov 05, 2018

SELL
$18.95 - $28.08 $356,392 - $528,100
-18,807 Reduced 22.75%
63,873 $1.29 Million
Q2 2018

Jul 31, 2018

BUY
$20.0 - $29.72 $168,000 - $249,648
8,400 Added 11.31%
82,680 $1.96 Million
Q1 2018

Apr 27, 2018

BUY
$21.69 - $32.99 $1.61 Million - $2.45 Million
74,280 New
74,280 $1.67 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.